Stem cell transplant, Rituxan hold ‘tremendous promise’ for ILD with systemic sclerosis – Healio
|
Stem cell transplant, Rituxan hold 'tremendous promise' for ILD with systemic sclerosis
Healio DESTIN, Fla. — Stem cell transplantation, rituximab and tocilizumab show considerable promise as treatments for interstitial lung disease in systemic sclerosis among select patients, according to findings presented at the 2018 Congress of Clinical … |
